Related resources
Full-text held externally
- DOI: 10.1038/ncponc0908
Search for item elsewhere
University researcher(s)
Academic department(s)
Origins of breast cancer subtypes and therapeutic implications.
Sims A, Howell A-, Howell S, Clarke RB
Nat Clin Pract Oncol. 2007;4( 9):516-25.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- DOI: 10.1038/ncponc0908
Abstract
This Review summarizes and evaluates the current evidence for the cellular origins of breast cancer subtypes identified by different approaches such as histology, molecular pathology, genetic and gene-expression analysis. Emerging knowledge of the normal breast cell types has led to the hypothesis that the subtypes of breast cancer might arise from mutations or genetic rearrangements occurring in different populations of stem cells and progenitor cells. We describe the common distinguishing features of these breast cancer subtypes and explain how these features relate both to prognosis and to selection of the most appropriate therapy. Recent data indicate that breast tumors may originate from cancer stem cells. Consequently, inhibition of stem-cell self-renewal pathways should be explored because of the likelihood that residual stem cells might be resistant to current therapies.
Keyword(s)
Female; Gene Expression Profiling; Humans; administration & dosage: Antineoplastic Agents; classification: Breast Neoplasms; genetics: Tumor Markers, Biological; pathology: Cell Transformation, Neoplastic; pathology: Stem Cells; therapeutic use: Antibodies, Monoclonal; therapeutic use: Selective Estrogen Receptor Modulators